The prognostic value of diarem and Ad-Diarem in patients with type 2 diabetes mellitus after bariatric surgery
https://doi.org/10.17238/2072-3180-2022-4-41-48
Abstract
Introduction. Bariatric surgery shows excellent results in the treatment of obesity and comorbidities including type 2 diabetes. To predict the effect of surgical treatment of type 2 diabetes mellitus, several scales have been proposed, including DiaRem and Ad-DiaRem.
Materials and methods of research. Based on a retrospective analysis study, 38 patients with type 2 diabetes were identified after bariatric surgery with a follow-up period of at least 1 year. The KNIME Analytics Platform 4.3.6 (KNIME AG, Switzerland) was used for data processing.
Treatment results. Among 38 patients, 12,8 % achieved partial remission of diabetes, 52,6 % complete remission, and 31,6 % did not achieve remission. According to the DiaRem, no significant results were detected in the remission groups (χ2 = 6,76, DF = 4, p-value = 0,15). AUC = 0,744, k = 0,383. DiaRem scale have a low predictive value. A significant result was obtained on the Ad-DiaRem (χ2 = 22,0, DF = 4, p-value = 0,0002). AUC = 0,88, k = 0,632. Ad-DiaRem predictive value is high.
Conclusion. The Ad-DiaRem have a better predictive value. Ease of use, good prognostic effect allows us to recommend Ad-DiaRem before bariatric treatment to. Duration of diabetes mellitus and number of hypoglycemic drugs taken seems to be one of the crucial factors in prognosis of DM remission.
About the Authors
A. E. NeimarkRussian Federation
Neimark Aleksandr Evgenevich – PhD, associate professor
eLibrary SPIN: 6554-3217
197341, 2 Akkuratova street, St. Petersburg
М. А. Molotkova
Russian Federation
Molotkova Mariia Aleksandrovna – Research Assistant
197341, 2 Akkuratova street, St. Petersburg
Е. О. Makarova
Russian Federation
Makarova Ekaterina Olegovna – Postgraduate student of the
Department of Endocrinology
197341, 2 Akkuratova street, St. Petersburg
M. I. Galchenko
Russian Federation
Galchenko Maxim Ivanovich – senior lecturer
eLibrary SPIN: 8858-2916
196601, 2 Peterburskoe sh, Pushkin, Saint-Petersburg
References
1. Boutari C., Mantzoros C. S. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism: Clinical and Experimental, 2022, № 133, pp. 1–7. https://doi.org/10.1016/j.metabol.2022.155217
2. Sun Н., Saeedi Р., Karuranga S., Pinkepank М., Ogurtsova К., Duncan B.B., Stein С., Basit А., Chan J.C.N., Mbanya J.C., Pavkov M.E., Ramachandaran A., Wild S.H., James S., Herman W.H., Zhang P., Bommer C., Kuo S., Boyko E.J, Magliano D.J. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract, 2022, № 183, pp. 1–13. https://doi.org/10.1016/j.diabres.2021.109119
3. Jakobsen G.S., Småstuen M., Sandbu R., Nordstrand N., Hofsø D., Lindberg M., Hertel J., Hjelmesæth J. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. JAMA - Journal of the American Medical Association, 2018, № 319 (3), pp. 291–301. https://doi.org/10.1001/jama.2017.21055
4. Kornyushin O. V., Sakeian I. S., Kravchuk E. N., Vasilevsky D. I., Danilov I. N., Neimark A. E. Prediction of remission of type 2 diabetes mellitus after bariatric surgery. Saharnyj Diabet, 2021, № 24 (6), pp. 565–570. (in Russ.) https://doi.org/10.14341/DM12814
5. Still C. D., Wood G. C., Benotti P., Petrick A. T., Gabrielsen J., Strodel W. E., Ibele A., Seiler J., Irving B. A., Celaya M. P., Blackstone R., Gerhard G. S., Argyropoulos G. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: A retrospective cohort study. Lancet Diabetes Endocrinol, 2014, № 2 (1), pp. 38–45. https://doi.org/10.1016/S2213-8587(13)70070-6
6. Aron-Wisnewsky J., Sokolovska N., Liu Y., Comaneshter D.S., Vinker S., Pecht T., Poitou C., Oppert J.-М., Bouillot J.-L., Genser L., Dicker D., Zucker J.-D., Rudich A., Clément K. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass. Diabetologia, 2017, № 60 (10), pp. 1892–1902. https://doi.org/10.1007/S00125-017-4371-7
7. Shen S.-C., Wang W., Tam K.-W., Chen H.-A., Lin Y.-K., Wang S.-Y., Huang M.-T., Su Y.-H. Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy. Obesity Surgery, 2018, № 29(1), pp. 221-229. https://doi.org/10.1007/s11695-018-3510-7
8. Fatima F., Hjelmesæth J., Hertel J. K., Svanevik M., Sandbu R., Småstuen M. C., Hofsø D. Validation of Ad-DiaRem and ABCD Diabetes Remission Prediction Scores at 1-Year After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in the Randomized Controlled Oseberg Trial. Obesity Surgery, 2022, № 32 (3), pp. 801–809. https://doi.org/10.1007/s11695-021-05856-2
9. Plaeke P., Beunis A., Ruppert M., de Man J. G., de Winter B. Y., Hubens G. Review, Performance Comparison, and Validation of Models Predicting Type 2 Diabetes Remission After Bariatric Surgery in a Western European Population. Obesity Surgery, 2021, № 31 (4), pp. 1549–1560. https://doi.org/10.1007/s11695-020-05157-0
10. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th Edition. М., 2021, 222 р. (in Russ.) https://doi.org/10.14341/DM12802
11. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care, 2021, № 44 (Supplement 1), pp. S15–S33. https://doi.org/10.2337/dc21-S002
12. Berthold M. R., Cebron N., Dill F., Gabriel T. R., Kötter T., Meinl T., Ohl P., Sieb C., Thiel K., Wiswedel B. KNIME: The Konstanz Information Miner. Studies in Classification, Data Analysis, and Knowledge Organization, 2007, pp. 319–326. https://doi.org/10.1007/978-3-540-78246-9_38
13. Kurgan L. А., Krzysztof J. C. CAIM discretization algorithm. IEEE Transactions on Knowledge and Data Engineering, 2004, № 16 (2), pp. 145–153. https://doi.org/10.1109/tkde.2004.1269594
14. McHugh M. L. Interrater reliability: the kappa statistic. Biochemia Medica, 2012, № 22 (3), pp. 276–82. https://doi.org/10.11613/BM.2012.031
Review
For citations:
Neimark A.E., Molotkova М.А., Makarova Е.О., Galchenko M.I. The prognostic value of diarem and Ad-Diarem in patients with type 2 diabetes mellitus after bariatric surgery. Moscow Surgical Journal. 2022;(4):41-48. (In Russ.) https://doi.org/10.17238/2072-3180-2022-4-41-48